Digital Digitalisation of pharma in 2025: What’s holding firms back? The ability to operate with real-time data, integrated systems, and validated automation is now essential.
Views & Analysis In the healthcare and life sciences jungle – industry must a... As the digital revolution takes hold, life sciences companies must evolve or face the consequences.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
